More Bad News At Boston Scientific: NexStent Recalled Due To Delivery Flaw
This article was originally published in The Gray Sheet
Executive Summary
Just as Boston Scientific is beginning to emerge from the quality control cloud it has been living under for the past couple years, FDA revealed Aug. 14 that the firm has recalled its NexStent carotid artery stenting system